+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Predictive value of cytokine genotyping for the risk of post transplant lymphoproliferative disease in solid organ transplant recipients



Predictive value of cytokine genotyping for the risk of post transplant lymphoproliferative disease in solid organ transplant recipients



Human Immunology 61(Suppl. 2): S138




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035536749

Download citation: RISBibTeXText


Related references

Cancer risk following post-transplant lymphoproliferative disorders in solid organ transplant recipients. British Journal of Haematology 186(2): 347-351, 2019

Post-transplant lymphoproliferative disease in pediatric solid organ transplant recipients. Pediatric Hematology and Oncology 30(6): 520-531, 2013

Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplant recipients, 1988-97: a Canadian multi-centre experience. Pediatric Transplantation 5(3): 198-203, 2001

Mini-BEAM and autologous peripheral blood hematopoietic stem cell transplant for treatment of post transplant lymphoproliferative disorders in solid organ transplant recipients Report of 2 cases. Blood 102(11): 738a, 2003

Utility of semiquantitative polymerase chain reaction for Epstein-Barr virus in peripheral blood lymphocytes among pediatric solid-organ transplant recipients with and without post-transplant lymphoproliferative disease. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 432, 1999

Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients. American Journal of Transplantation 11(4): 817-825, 2011

Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines. British Journal of Haematology 149(5): 675-692, 2010

Proposed prognostic model for survival in solid organ transplant recipients with post transplant lymphoproliferative disorders. Blood 102(11): 392a, 2003

Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines. British Journal of Haematology 149(5): 693-705, 2010

Managing post-transplant lymphoproliferative disorders in solid-organ transplant recipients: a review of immunosuppressant regimens. Drugs 72(12): 1631-1643, 2012

Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients. Clinical Microbiology and Infection 20(Suppl. 7): 109-118, 2014

Post-transplantation lymphoproliferative disorders in bone marrow transplant and solid organ transplant recipients differ. Laboratory Investigation 80(3): 144A, 2000

The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients. Journal of Cancer Research and Clinical Oncology 144(8): 1569-1580, 2018

The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients. Pediatric Transplantation 3(4): 271-281, 1999

EBV DNA quantitation in serum is highly correlated with the development and regression of post-transplant lymphoproliferative disorder in solid organ transplant recipients. Blood 92(10 Suppl. 1 Part 1-2): 314A-315A, 1998